Related Experiment Video
Updated: Mar 19, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Pulse Therapy in Pemphigus: Ready Reckoner
Anil Abraham1, Gillian Roga1, Anupa Mary Job1
1Department of Dermatology, St. John's Medical College and Hospital, Bengaluru, Karnataka, India.
Pulse therapy, a common treatment for pemphigus, involves high-dose intravenous steroids and immunosuppressants. This article clarifies its administration, efficacy, and addresses ongoing debates for dermatology residents.
Area of Science:
- Dermatology
- Immunology
- Pharmacology
Background:
- Pulse therapy is a widely used treatment for pemphigus.
- Concerns persist regarding the rationale for high-dose intravenous steroids and immunosuppressants in pulse therapy.
Purpose of the Study:
- To clarify the administration of pulse therapy for pemphigus.
- To address controversies and modifications in pulse therapy for pemphigus.
- To provide guidance for dermatology residents on pulse therapy protocols.
Main Methods:
- Review of existing literature on pemphigus pulse therapy.
- Analysis of reported controversies and modifications in treatment protocols.
- Synthesis of evidence regarding efficacy and methodology.
Main Results:
- Established efficacy and methodology of pulse therapy for pemphigus.
- Identified key areas of debate concerning steroid and immunosuppressant use.
- Highlighted recent modifications and alternative approaches in pulse therapy.
Conclusions:
- Pulse therapy remains a valuable treatment for pemphigus, despite ongoing discussions.
- Understanding the rationale and modifications is crucial for optimal patient outcomes.
- Further research may refine current pulse therapy guidelines for pemphigus management.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...

